New Board-Certified Hematology/Oncology Physician Joins DHR Health

Translate to Spanish or other 102 languages!

DHR Health Oncology Institute Welcomes Relindis N. Azenwi Fru, M.D. to the Rio Grande Valley. DHR Health Image
DHR Health Oncology Institute Welcomes Relindis N. Azenwi Fru, M.D. to the Rio Grande Valley. DHR Health Image

Mega Doctor News

- Advertisement -

Edinburg, TX – DHR Health is excited welcome Relindis N. Azenwi Fru, M.D. to their compassionate team of hematologists and oncologists at the DHR Health Oncology Institute in Edinburg, TX. 

Prior to joining DHR Health, Dr. Azenwi Fru was a Resident Physician in the Department of Internal Medicine at The University of Texas Medical Branch – Galveston, and a Fellowship Physician of Hematology and Oncology at Roger Williams Medical Center in Providence, RI shortly after receiving a Doctor of Medicine from The Commonwealth Medical College in Scranton, PA in 2015. 

She has been board certified by the American Board of Internal Medicine since 2018, and is a member of the American College of Physicians and Texas Medical Association.

- Advertisement -

The dedicated team player is also a proud Captain in the US Army Reserve.

Dr. Azenwi Fru is credited with creating a community outreach program to promote cervical cancer awareness and provide affordable screening and immunizations in the local communities of the South West Region of Cameroon. As a member of the Cameroonian-American Foundation of Michigan, the well-rounded Dr. Azenwi Fru educated teens and adolescents of African descent on the dangers of alcohol and drug abuse.

She will play an integral part in providing extensive medical care, treatment and support to cancer patients in the Rio Grande Valley.

When she isn’t treating cancer patients and encouraging cancer awareness, Dr. Azenwi spends time cooking and dancing to African folk music with her children and husband.

- Advertisement -

For more information on the services provided at DHR Health Oncology Institute or to schedule an appointment with Dr. Relindis N. Azenwi Fru, please call (956) 362-2250 or visit our website at www.dhrhealth.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 
- Advertisement -